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Abstract
Nosocomial infections with methicillin-resistant Staphylococcus aureus (MRSA) account for increased morbidity, mortality and healthcare
costs in critically ill patients worldwide. The intensive care unit (ICU) component of the German surveillance system for nosocomial
infections (Krankenhaus-Infektions-Surveillance-System, KISS) has been supplemented with a module targeting the surveillance of multi-
resistant pathogens [Multiresistente Erreger (MRE)-KISS] in order to account for the increasing burden of antibiotic-resistant bacteria.
The aim of this study was to assess the association between structural and organizational characteristics of ICUs and the number of
nosocomial MRSA cases. Data were derived from routine data collected in the frame of the national surveillance system of nosocomial
infections (ICU- and MRE-KISS) from January 2007 to December 2008 and from a questionnaire inquiring about structure and process
parameters. One hundred and forty ICUs performing active screening have been included. Process parameters such as isolation of
MRSA patients, decolonization procedures and introduction of MRSA alert systems have been implemented by the majority of the ICUs,
whereas the application mode of screening procedures and pre-emptive isolation measures is heterogeneous. Multivariable analysis using
negative binominal regression models shows that a stay on a medical ICU has a protective effect (incidence rate ratio, 0.42; 95% conﬁ-
dence interval, 0.24–0.74; p = 0.003), whereas the imported MRSA incidence is signiﬁcantly associated with the number of nosocomial
MRSA cases (incidence rate ratio, 1.74; 95% conﬁdence interval, 1.23–2.45; p = 0.002). Structure and process parameters do not show
any effect. ICU type and imported MRSA incidence should be considered for benchmarking between hospitals.
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Introduction
Nosocomial infections with multiresistant bacteria, particu-
larly methicillin-resistant Staphylococcus aureus (MRSA), play
an increasing role in the hospital care of critically ill patients
[1]. In Germany, the percentage of MRSA in relation to
Staphylococcus aureus isolates derived from blood cultures
increased from 9% in 1999 to 20% in 2002 [2]. However, in
recent years the proportion of MRSA-positive isolates
appears to have stagnated in German hospitals, probably due
to enhanced infection control measures [3,4].
Cross-transmission by direct contact, such as hands of
healthcare workers and visitors and a contaminated environ-
ment (e.g. equipment), is an important and preventable cause
of the spread of MRSA in hospitals. In order to prevent and
control nosocomial MRSA infections, a comprehensive strat-
egy comprising surveillance of nosocomial infections and the
spread of MRSA, personal and institutional hygiene measures,
surveillance of antibiotic resistance and usage and measures
to ensure prudent antibiotic use (e.g. antibiotic stewardship
programmes) is necessary [5].
In Germany, a national surveillance system for nosocomial
infections has been introduced (Krankenhaus-Infektions-
Surveillance-System, KISS) in 1997 [6]. Nosocomial infections
in ICUs were recorded in the ICU component of KISS (ICU-
KISS). In 2003, ICU-KISS has been supplemented by the mul-
tiresistant microorganisms module [Multiresistente Erreger
(MRE)-KISS] in order to account for the growing impact of
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multiresistant bacteria [7]. Besides infection control and
prevention practices, structural parameters of ICUs and
hospitals, such as size and type of hospitals and ICUs, the
equipment in single bedrooms and ventilator places, may
have an inﬂuence on the frequency of nosocomial MRSA
cases. So far, a systematic investigation of the effect of struc-
tural factors on hospital MRSA acquisition has rarely been
performed. The aim of this study is to obtain data on struc-
tural and organizational characteristics of ICUs participating
in ICU- and MRE-KISS and to analyse the association of
these factors with the number of nosocomial MRSA cases.
Data are derived from routine surveillance reports combined
with a structured questionnaire from 140 German ICUs par-
ticipating in ICU- and MRE-KISS in 2007/2008.
Methods
Monthly recorded numbers of patients, patient days, device
days (ventilator, central venous catheter and urinary tract
catheter) and patient-based MRSA cases were derived from
routine data collected in the frame of the national surveil-
lance system of nosocomial infections (ICU- and MRE-KISS)
from January 2007 to December 2008.
In March 2008, a web-based questionnaire was sent out
to all ICUs participating in ICU- and MRE-KISS to collect
information on structural characteristics and measures for
prevention and infection control. From 275 ICUs, 185
(67.3%) questionnaires were completed.
Only those 140 ICUs that perform active screening for
MRSA have been included in the analysis, in order to allow
for the estimation of nosocomial MRSA acquisition.
The recorded data comprise the following.
Structural parameters: type and size of hospitals and ICUs,
geographical region, and number of ventilator places, single
bedrooms and ICUs per hospital.
Process and MRSA prevention parameters: length of stay,
device utilization rate, employed staff, proportion of short
stayers (£48 h), implementation of an MRSA alert system,
screening for MRSA on admission, type of screening per-
formed (patients at high risk of MRSA, or all patients), time
point of screening, pre-emptive isolation, isolation of con-
ﬁrmed MRSA patients, and decolonization measures.
The following deﬁnitions have been used.
MRSA case: every patient in whom MRSA has been
detected at any body site during his/her stay on the ICU,
irrespective of whether the patient presents with symptoms
of infection or is merely colonized.
Nosocomial MRSA case: detection of MRSA more than
48 h after admission to the ICU, either as a result of the
performance of screening cultures or the investigation of
clinical samples.
Imported MRSA case: detection of MRSA within 48 h after
admission to the ICU.
MRSA incidence density: number of MRSA cases/1000
patients.
Nosocomial MRSA incidence density: number of nosoco-
mial MRSA cases/1000 patient-days.
Imported MRSA incidence: number of imported MRSA
cases/100 patients.
Device utilization rate: number of device days/100 patient-
days. These rates are calculated separately for invasive venti-
lation, central venous catheters (CVC) and urinary tract
catheters (UTC).
Staff-patient ratio: number of actually employed staff/
patient/day/shift.
Data analysis
The results of descriptive analysis are presented as summary
measures appropriate to the data type and distribution. For
categorial variables data are expressed in numbers and per-
centages, and for continuous variables in means and standard
deviation (SD) if the variables showed a normal distribution
or in medians with interquartile ranges (IQR) for non-
normally distributed variables.
Univariate and multivariable analysis has been performed to
identify independent risk factors for nosocomial MRSA cases.
A negative binominal regression model has been used to
estimate the association of the number of nosocomial MRSA
cases with the parameters. The log number of patient days
was treated as an offset in the model. As the magnitude of
the variance of the outcome parameter indicates overdisper-
sion and the dispersion parameter alpha of the likelihood
ratio test, which differs signiﬁcantly from zero, also conﬁrms
the presence of overdispersion, negative binominal regres-
sion has been used instead of poisson regression. Compari-
son with a zero inﬂated model using the Vuong test did not
show any advantage over negative binominal regression.
For multivariable analysis a stepwise forward approach has
been applied, which considered all variables with a p-value of
<0.25 in univariable analysis. The p-value for retention of a
covariate in the model was 0.05 to identify independent risk
factors.
Comparisons between ICU types and between different
hospital sizes have been performed by using the Kruskal–
Wallis test and the Wilcoxon rank sum test, respectively.
Calculations have been performed using STATA version 9.
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Results
In 140 ICUS, coming from all major geographical regions in
Germany, a total of 228 703 patients, accounting for
852 835 patient days, have been treated in 2007/2008. From
4279 MRSA cases 3496 (81.7%) were contracted from out-
side the hospital and 783 (18.3%) were classiﬁed as nosoco-
mial in the ICU.
MRSA situation
The numbers and rates of MRSA in the ICUs are shown in
Table 1. Stratiﬁcation by ICU type shows that medical ICUs
exhibit signiﬁcant (p = 0.02) lower numbers of nosocomial
MRSA cases/month (median, 0.07; IQR, 0–0.33) as compared
with interdisciplinary (median, 0.17; IQR, 0.04–0.42) and surgi-
cal ICUs (median,: 0.29; IQR, 0.10–0.54) and show a lower
incidence density of nosocomial MRSA cases (p = 0.006) as
well, presenting with a median incidence of nosocomial MRSA/
1000 patient-days of 0.24 (IQR, 0–0.82) in contrast to interdis-
ciplinary and surgical ICUs, which show a median value of 0.64
(IQR, 0.26–1.50) and 0.93 (IQR, 0.41–1.45), respectively.
Comparison of the MRSA parameters stratiﬁed by hospital
size (hospitals £1000 beds and hospitals >1000 beds) reveals a
higher MRSA incidence density and a higher incidence of
imported MRSA in large hospitals >1000 beds (Wilcoxon rank
sum test, p <0.001 and p <0.001, respectively), whereas the
nosocomial MRSA incidence densities do not show any differ-
ences (Wilcoxon rank sum test, p = 0.34).
Structural and organizational characteristics
Structural and organizational characteristics of the ICUs are
shown in Table 2. The largest proportion of the participating
hospitals was classiﬁed as academic teaching hospitals (50%).
The hospitals were broadly evenly distributed over the main
geographical regions in Germany. Ninety-ﬁve (67.9%) hospi-
tals have 1000 beds or less and 65 (46.4%) participating ICUs
are classiﬁed as interdisciplinary. While 51 (36.4%) ICUs
screen all patients, 89 (63.6%) ICUs restrict screening to
patients at particular risk, including previously known MRSA
patients and contact patients. The majority (86.4%) of the
ICUs perform screening at the patient’s admission, while
only a smaller proportion (27.9%) applied screening at regu-
lar intervals during their stay. Twenty (14.3%) ICUs combine
both strategies. From the 51 ICUs screening all patients, only
14 (27.4%) perform prophylactic isolation measures. In con-
trast, most ICUs arrange single room isolation of MRSA
patients.
Association of nosocomial MRSA cases with structure, pro-
cess and MRSA-prevention measures of the ICUs
The results of univariate analysis to assess the association
between nosocomial MRSA cases and structure, process and
MRSA-prevention measures of the ICUs are shown in
Table 2. Medical ICUs showed a signiﬁcantly lower number
of nosocomial MRSA cases than interdisciplinary and surgical
ICUs. The incidence rate ratio (IRR) for nosocomial MRSA
cases was 0.48 (95% conﬁdence interval (CI), 0.31–0.74)
compared with interdisciplinary ICUs. Teaching hospitals and
‘other hospital types’ experience a lower number of nosoco-
mial MRSA cases than university hospitals, but not statisti-
cally signiﬁcantly lower. Similiarly, hospital size does not
appear to be related to the number of nosocomial MRSA
cases, while ICU sizes of ‡12 beds are associated with more
nosocomial MRSA cases (IRR = 1.49; 95% CI, 1.04–2.13).
Increased application of devices such as UTCs was associated
with a higher rate of nosocomial MRSA cases. The higher
incidence of imported MRSA (>0.94) is associated with a
1.8-fold increase in the rate of nosocomial MRSA cases,
compared with the lower incidence of imported MRSA.
Multivariable analysis (Table 3) conﬁrms that type of ICU
and incidence of imported MRSA cases were independent
risk factors for nosocomial MRSA acquisition. The adjusted
IRR for medical ICUs, compared with interdisciplinary ICUs,
was 0.42 (95% CI, 0.24–0.74) and for ICUs with an incidence
of imported MRSA cases greater than the median was 1.74
TABLE 1. Cases and rates of methicillin-resistant Staphylococcus aureus (MRSA) in the 140 intensive care units (ICUs), strati-
ﬁed by type of ICU
Parameter
All ICUs
median (IQR)
Interdisciplinary ICUs
median (IQR)
Medical ICUs
median (IQR)
Surgical ICUs
median (IQR) p-valuea
Number of MRSA cases per month (n/month) 1.0 (0.35–1.96) 0.79 (0.41–1.75) 0.92 (0.33–2.04) 1.38 (0.63–2.08) 0.330
Number of nosocomial MRSA cases per month (n/month) 0.16 (0.04–0.47) 0.17 (0.04–0.42) 0.07 (0–0.33) 0.29 (0.10–0.54) 0.020
Incidence density of MRSAb 3.66 (1.51–6.10) 3.34 (1.30–5.71) 2.94 (1.07–6.06) 3.94 (2.36–6.48) 0.500
Incidence density of nosocomial MRSAc 0.59 (0.15–1.35) 0.64 (0.26–1.50) 0.24 (0–0.82) 0.93 (0.41–1.45) 0.006
Incidence of imported MRSAd 0.94 (0.35–2.22) 0.68 (0.36–1.58) 0.94 (0.27–2.65) 1.24 (0.50–2.48) 0.380
Median days to nosocomial MRSA case (days) 13.0 (9.0–18.0) 13.0 (9.0–17.5) 14.5 (5.0–19.5) 12.0 (9.0–18.0) 0.990
aKruskal–Wallis rank test.
bIncidence density of MRSA, number of MRSA/1000 patient days.
cIncidence density of nosocomial MRSA, number of nosocomial MRSA/1000 patient days.
dIncidence of imported MRSA, number of imported MRSA/100 patients.
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(95% CI, 1.23–2.46) as compared with those with imported
MRSA incidences lower than the median.
Discussion
Multivariable analysis shows that the incidence of imported
MRSA is signiﬁcantly associated with the number of nosoco-
mial MRSA cases in ICUs and that stay on medical ICUs has
a protective effect. The latter result does not contradict for-
mer studies, which found surgical ICUs to be at particular
risk of presenting with high MRSA infection rates [8,9]. The
lower number of nosocomial MRSA cases in medical ICUs is
probably due to differences in patient characteristics
between conservative and surgical medicine with respect to
gender, age, underlying diseases, severity of disease,
frequency of invasive procedures and antibiotic therapy.
Patient-level risk factors have been extensively investigated in
former studies [10–12].
TABLE 2. Summary of structure, process and MRSA
parameters in 140 intensive care units (ICUs) and their
association with the number of nosocomial MRSA cases:
univariate negative binomial regression model
Characteristic Number (%)
Incidence rate
ratio (95%CIa) p-value
Structure parameters
Type of ICU
Interdisciplinary 65 (46.4) Reference 0.001
Medical 34 (24.3) 0.48 (0.31–0.74)
Surgical 41 (29.3) 1.09 (0.74–1.63)
Size of ICU
£12 beds 78 (55.7) Reference 0.030
>12 beds 62 (44.3) 1.49 (1.04–2.13)
Type of hospital
University 29 (20.7) Reference 0.490
Teaching 70 (50.0) 0.75 (0.45–1.20
Other 41 (29.3) 0.83 (0.50–1.40)
Size of hospital
<1000 beds 95 (67.9) Reference 0.542
‡1000 beds 45 (32.1) 1.13 (0.77–1.65)
Geographical region
East 33 (23.6) Reference 0.611
South-east 31 (21.1) 0.74 (0.44–1.25)
South-west 22 (15.7) 1.18 (0.66–2.10)
North 21 (15.0) 0.95 (0.53–1.69)
West 33 (23.6) 1.02 (0.61–1.70)
Number of ICUs in the hospital
1–2 77 (55.0) Reference 0.881
3–13 63 (45.0) 0.97 (0.68–1.40)
Percentage of single bedrooms/all ICU beds (median, IQR) 20.7 (11.8–36.9)
£21% Reference 0.562
>21% 1.11 (0.78–1.6)
Number of ventilation places/all ICU beds (median, IQR) 80.0 (50.0–100)
£80 Reference 0.620
>80 1.09 (0.77–1.57)
Staff-patient ratiob (median, IQR) 0.93 (0.79–1.06)
£0.93 Reference 0.42
>0.93 0.86 (0.60–1.24)
Portion of short stayers
<1/3 50 (35.7) Reference 0.342
1/3–2/3 77 (55.0) 0.78 (0.52–1.12)
‡2/3 13 (9.3) 1.01 (0.54–1.92)
Process parameters
Length of stay in days (median, IQR) 3.8 (2.9–5.1)
£4 Reference 0.262
>4 1.23 (0.86–1.78)
CVC ratec (mean, SD) 68.1 (18.0)
<55.4 Reference 0.050
55.4–70.6 1.28 (0.78–2.13)
70.7–81.1 2.00 (1.21–3.29)
>81.1 1.28 (0.78–2.11)
UTC rated (mean, SD) 80.4 (13.7)
<73.8 Reference 0.001
73.9–82.9 1.96 (1.18–3.25)
83.0–89.9 2.62 (1.59–4.34)
>89.9 2.33 (1.41–3.89)
Invasive ventilation ratee (mean, SD) 40.0 (17.1)
<26.7 Reference 0.110
26.8–38.3 1.38 (0.82–2.32)
38.4–50.8 1.78 (1.07–2.97)
>50.8 1.72 (1.03–2.87)
MRSA parameters
Incidence of imported MRSAf (median, IQR) 0.94 (0.35–2.22)
£0.94 Reference 0.001
>0.94 1.81 (1.28–2.55)
Alert system for MRSA
No 18 (12.9) Reference 0.708
Yes 122 (87.1) 1.11 (0.64–1.93)
Screening
Of risk patientsg 89 (63.6) Reference 0.560
Of all patients 51 (36.4) 1.03 (0.90–1.19)
Timepoint of screening
At admission only 101 (72.1) Reference 0.255
Regularly only 19 (13.6) 1.21 (0.72–2.06)
At admission and regularly 20 (14.3) 1.50 (0.91–2.46)
Pre-emptive isolation of all patients on ICUs screening all admitted patients
No 37 (72.6) Reference 0.190
Yes 14 (27.4) 1.50 (0.82–2.71)
TABLE 2. (Continued)
Characteristic Number (%)
Incidence rate
ratio (95%CIa) p-value
Single room isolation of MRSA patients
No 10 (7.1%) Reference 0.463
Contact precautions only 118 (84.3) 0.72 (0.37–1.39)
Single room isolation 12 (88.6) 0.57 (0.24–1.39)
Decolonization of MRSA patients
No 10 (7.6) Reference 0.980
Mupirocin only 26 (19.7) 0.93 (0.42–2.07)
Mupirocin and antiseptic washings 96 (72.7) 0.93 (0.46–1.89)
aCI, conﬁdence interval.
bStaff-patient ratio, number of staff/patient/day/shift.
cCVC rate, central venous catheter-rate; number of CVC-days/100 patient-days,
quartiles.
dUTC rate, urinary tract catheter rate; number of UTC-days/100 patient days,
quartiles.
eInvasive ventilation rate, number of invasive ventilation-days/100 patient-days,
quartiles.
fIncidence of imported MRSA, number of imported MRSA/100 patients.
gFor example, patients with chronic wounds, previous stay in a healthcare facility
and other risk factors.
TABLE 3. Results of multivariable analysis of structure and
process parameters of 140 ICUs participating in ICU- and
MRE-KISS using negative binomial regression for the out-
come: number of nosocomial MRSA cases (log number of
patient-days as offset variable)
Variable Incidence rate ratio 95% CIa p-value
ICU type
Interdisciplinary Reference
Medical 0.42 0.24–0.74 0.003
Surgical 1.01 0.64–1.60 0.960
Incidence of imported MRSAb
£0.94 Reference
>0.94 1.74 1.23–2.45 0.002
a95% conﬁdence interval.
bIncidence of imported MRSA, number of imported MRSA/100 patients.
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The incidence of imported MRSA cases showed a highly
signiﬁcant association with nosocomial MRSA cases, which is
plausible because with the increase of the MRSA-positive
reservoir the probability of transmission to other patients
rises. This result is conﬁrmed by several other studies, which
showed that colonization pressure is an independent risk fac-
tor for hospital MRSA acquisition [13–15]. In order to
account for this close relationship some authors proposed
using adjusted MRSA transmission rates for intra- and inter-
hospital comparisons [16,17]. This has to be considered with
caution, as the measures characterizing colonization pressure
might be strongly inﬂuenced by the screening policy of the
hospitals [18].
In multivariable analysis none of the structural parame-
ters showed an association with the number of nosocomial
MRSA cases. Previous data on the relationship of structural
properties of hospitals and ICUs with MRSA acquisition
rates are scarce. Grammatico-Guillon et al. [8] investigated
the relationship of MRSA prevalence and infection control
indicators in French hospitals in 2005/2006. They found that
private for-proﬁt hospitals present with the lowest MRSA
prevalence, but this could be explained by the speciﬁc
patient population. Hospital ownership has not been consid-
ered in the present study. Mears et al. [19] found a rela-
tionship between availability of single bedrooms and
nosocomial MRSA rates, which could not be conﬁrmed in
the present study. Another study shows merely descriptive
data [20]. The overall negative results imply that probably
other factors, which have not been considered in the pres-
ent study, such as patient-level characteristics, may play a
more important role in determining the amount of nosoco-
mial MRSA cases. Another reason might be that hospitals
participating in MRE-KISS are too homogenous to detect
any differences.
Process-indicators of infection control and prevention
measures also did not yield a signiﬁcant effect in multivariable
analysis, which is mainly due to the design of the study,
which enables an analysis of the actual situation but does not
allow estimating the temporal relationship of dependant and
independent variables. Nevertheless, the data give insight
into the current situation and provide a basis for the evalua-
tion of future developments.
Descriptive data show that a wide range of hospital and
ICU types and sizes from all major regions of Germany are
represented. Most of the infection control and prevention
measures are implemented in the majority of the ICUs.
Screening and pre-emptive isolation practices, which have
been investigated in more detail, provide a more heteroge-
neous picture. Regarding general organizational factors, such
as staff-patient ratio, portion of short-stayers and MRSA-
speciﬁc infection control measures, no signiﬁcant differences
between ICU types have been seen.
Despite the overall impression of a similar approach in
combating the hospital spread of MRSA, underlying heteroge-
neities can not be excluded. As standardized deﬁnitions are
missing, the question regarding screening of patients at risk
does not specify which patients should be considered to be
at risk. As ICUs use individual risk deﬁnitions, a positive
answer comprises different screening strategies. Additionally,
there is no information on other determinants of screening
policy, such as the site of screening, which inﬂuences the
yield of MRSA cases [21,22]. Similarly, staff-patient ratio is an
important determinant of hospital staff policy, but reﬂects
only one component of a multifaceted entity. Several other
factors, such as bed occupancy and workload, should be
considered in order to provide a more comprehensive
picture [23].
Another limitation of the study regards the different
screening policies, which might result in misclassiﬁcation. As
only 27.9% of the ICUs screen for MRSA at regular intervals
(e.g. two ﬁxed days a week), an underestimation of the
nosocomial transmission rate has to be assumed. On the
other hand, those ICUs that do not screen at admission
(13.6%) but perform screening at regular intervals might
overlook imported MRSA cases and misclassify imported
MRSA cases as hospital acquired.
As the response rate in the study was 67.3% and after
exclusion of the non-screeners only 50.9% participants
remained, selection bias has to be considered and represen-
tativity of the study population for all screening ICUs partici-
pating in MRE-KISS can not be warranted. Furthermore,
hospitals and ICUs deciding to participate in ICU- and MRE-
KISS might differ systematically from those that do not take
part in a surveillance system. Thus, the representativity for
all German ICUs is difﬁcult to assess.
Another important point to consider is the size of the
study. As the study sample is relatively small, it can be
assumed that the power is not sufﬁcient to detect small dif-
ferences. For future studies efforts should be made to
enhance the participation rate.
Compliance with infection control procedures, one aspect
known to have substantial inﬂuence on the effectivity of
infection control interventions, has not been addressed in
the study [24,25]. Hence, appraisal of the study results
should take account of this problematic factor. In this con-
text it should also be kept in mind that the variables that
have been included in the study represent only a proportion
of the whole spectrum of infection control measures aiming
to prevent nosocomial infections as well as the spread of
multiresistant pathogens. Thus, there may be several
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confounding and/or interacting factors, which may not have
been considered but nevertheless make an essential contri-
bution to the outcome-measure.
In conclusion, multivariate analysis did not reveal any risk
factors or protective effects originating from the structural
set-up of hospitals and ICUs and from organizational inter-
ventions targeting prevention and control of the spread of
MRSA. Nevertheless, it could be shown that medical ICUs
experience lower nosocomial MRSA case rates than the
other ICU types and that the imported MRSA incidence is
signiﬁcantly associated with higher numbers of nosocomial
MRSA cases. This point should be considered when bench-
marking between hospitals.
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